Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Osiris Falls despite Narrower Q2 Loss and Higher Revenues
Yahoo/Zacks.com
Monday, August 11, 2014 - 11:52am
tags:
Osiris, earnings
New use for Bayer's Eylea in EU gives it more market power against Novartis' Lucentis
Fierce Pharma
Monday, August 11, 2014 - 11:51am
tags:
Europe, Novartis, Lucentis, Eylea, Bayer
FDA Accepts First-Ever Biosimilar Application for Monoclonal Antibody
RAPS.org
Monday, August 11, 2014 - 11:13am
tags:
Remsima, Remicade, monoclonal antibodies, FDA, Celltrion, biosimilars
Big Investors ask Drug Maker Boards not to Denigrate Biosimilars
WSJ Online
Monday, August 11, 2014 - 10:59am
tags:
biosimilars
Ebola Drug Maker Tekmira Shares Are Exploding Higher Again
Yahoo/Business Insider
Monday, August 11, 2014 - 10:54am
tags:
ebola virus, TKM-EBOLA, Tekmira Pharmaceuticals
J&J's diabetes combo wins FDA nod in a fast-crowding space
Fierce Biotech
Monday, August 11, 2014 - 10:53am
tags:
JNJ, diabetes, FDA, Invokamet
Med tech M&A gets much, much bigger during the first half
Fierce Medical Devices
Monday, August 11, 2014 - 8:52am
tags:
M&A, devices, Medtronic, Covidien, Zimmer, Biomet, Smith & Nephew, ArthroCare, Carlyle, Ortho Clinical Diagnostics, Sauflon, Cooper Companies
Sanofi fills some big shoes in $925M Afrezza pact with MannKind
Fierce Biotech
Monday, August 11, 2014 - 8:48am
tags:
Sanofi, MannKind, insulin, Afrezza, inhaled insulin, diabetes
Clinical trial to start soon on GSK Ebola vaccine
Reuters
Monday, August 11, 2014 - 8:44am
tags:
GSK, ebola virus, vaccines, Okairos
Most popular news headlines for Friday, August 8 2014
CP Wire
Monday, August 11, 2014 - 8:41am
tags:
Allergan, China, diabetes, ebola virus, FDA, GSK, Lipitor, M&A, Pfizer, Tekmira Pharmaceuticals, TKM-EBOLA, Valeant Pharmaceuticals
Biodel's insulin drug found effective in trial
Yahoo/Reuters
Monday, August 11, 2014 - 8:01am
tags:
Biodel, insulin, diabetes, BIOD-531
Sanofi bets on inhaled insulin with up to $925 mln MannKind deal
Yahoo/Reuters
Monday, August 11, 2014 - 7:59am
tags:
MannKind, Sanofi, diabetes, inhaled insulin, Afrezza, insulin
Teva To Sue Dr. Reddy’s Over Generic Copaxone
Jewish Business News
Sunday, August 10, 2014 - 10:29am
tags:
Teva, Dr Reddy's, lawsuits, generics
Delaware Court of Chancery Orders SIGA To Pay PharmAthene Lump Sum Expectation Damages
Yahoo/PR NewsWire
Sunday, August 10, 2014 - 10:21am
tags:
SIGA technologies, PharmAthene, lawsuits, Tecovirimat, ST-246
Op-Ed: New U.S. body to evaluate antimicrobial products
Digital Journal
Saturday, August 9, 2014 - 9:45am
tags:
antimicrobials, antibiotics
US action won't reverse tax 
'inversion' - Endo boss
The Irish Independent, Ireland
Saturday, August 9, 2014 - 9:35am
tags:
Endo
Neuralstem Pipeline Rolling Forward, Tackling Major Unmet Needs
Yahoo/Zacks
Saturday, August 9, 2014 - 9:25am
tags:
Neuralstem
California judge sets Aug. 20 hearing in Allergan vs Valeant case
Yahoo/Reuters
Friday, August 8, 2014 - 5:55pm
tags:
California, Allergan, Valeant Pharmaceuticals, M&A
Neurocrine To Move Tardive Dyskinesia Drug Into Phase 3
Yahoo/Zacks.com
Friday, August 8, 2014 - 5:55pm
tags:
tardive dyskinesia, Neurocrine Biosciences, NBI-98854, earnings
GW Pharma, Insys Face Off In Cannabis Drug Space
Investors.com
Friday, August 8, 2014 - 5:53pm
tags:
GW Pharma, Insys, cannabis, Medical Marijuana

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.